By Counterforce Health Team in Entresto (sacubitril/valsartan) —

How to Get Entresto (sacubitril/valsartan) Covered by UnitedHealthcare in California: Prior Authorization, Appeals, and Coding Guide

Answer Box: Getting Entresto Covered by UnitedHealthcare in California

UnitedHealthcare requires prior authorization for Entresto (sacubitril/valsartan) in California, with approval typically taking 72 hours when proper documentation is submitted. Your fastest path: (1) Have your cardiologist submit a PA through the UHC provider portal with your heart failure diagnosis, ejection fraction, and ACE inhibitor/ARB transition plan, (2) If denied, file an internal appeal within 180 days, then (3) Request California's Independent Medical Review (IMR) for binding external review. Start today: Call UnitedHealthcare member services to confirm your plan's formulary status and PA requirements.

Table of Contents

  1. UnitedHealthcare Prior Authorization Requirements
  2. Medical vs. Pharmacy Benefit Coding
  3. ICD-10 Documentation for Heart Failure
  4. Clean Prior Authorization Submission
  5. Common Denial Reasons & Solutions
  6. California Appeals Process
  7. Cost-Saving Options
  8. When to Escalate to State Regulators
  9. Frequently Asked Questions

UnitedHealthcare Prior Authorization Requirements

UnitedHealthcare's OptumRx division manages Entresto coverage under Program 2024 P 2064-14, requiring prior authorization for most commercial plans in California.

Coverage at a Glance

Requirement What It Means Documentation Needed Timeline
Prior Authorization PA required before filling Clinical criteria form + records 72 hours standard
Heart Failure Diagnosis Chronic HF with symptoms ICD-10 I50.xx, NYHA class Current visit note
Ejection Fraction LVEF ≤40% or structural disease Echo report within 6-12 months Must include date/value
ACE/ARB Transition 36-hour washout from ACEi Medication timeline in chart Explicit documentation
Cardiology Involvement Specialist consultation required Note or co-signature Can be consultation
Beta-blocker Therapy Guideline-directed HF treatment Current medication list Include dose/duration

Step-by-Step: Fastest Path to Approval

  1. Confirm Plan Coverage (Patient/Clinic)
    • Call UnitedHealthcare member services
    • Verify Entresto is on formulary with PA requirement
    • Get PA form and submission instructions
    • Timeline: Same day
  2. Gather Clinical Documentation (Clinic)
    • Recent echocardiogram with LVEF
    • Heart failure diagnosis with NYHA class
    • Current medication list including beta-blocker
    • ACE inhibitor/ARB history and transition plan
    • Timeline: 1-2 business days
  3. Submit Prior Authorization (Prescriber)
    • Complete UHC PA form
    • Submit via UHC provider portal or fax
    • Include letter of medical necessity
    • Timeline: Same day submission
  4. Track Decision (Clinic/Patient)
    • Standard review: 72 hours
    • Expedited review: 24-48 hours for urgent cases
    • Check portal or call for status updates
    • Timeline: 1-3 business days

Medical vs. Pharmacy Benefit Coding

Entresto is an oral medication that typically processes through the pharmacy benefit using NDC codes, not medical benefit HCPCS codes.

Pharmacy Benefit (Standard)

  • Billing Method: NDC number through retail or specialty pharmacy
  • Coverage: Medicare Part D, commercial prescription benefit
  • Prior Auth: Required through OptumRx
  • No J-code needed: Oral tablets don't use HCPCS codes

Medical Benefit (Rare Exception)

  • When Used: Inpatient administration or feeding tube delivery
  • HCPCS Code: J3490 (Unclassified drugs) + NDC
  • Documentation: Route of administration, medical necessity
  • Pre-approval: Must verify with UHC before billing
Note: Always bill through pharmacy benefit first. Medical benefit coverage for oral Entresto is uncommon and requires specific payer approval.

ICD-10 Documentation for Heart Failure

Precise ICD-10 coding supports prior authorization approval and proper reimbursement.

Primary Heart Failure Codes

Systolic Heart Failure (HFrEF)

  • I50.22 - Chronic systolic heart failure (most common for Entresto)
  • I50.23 - Acute on chronic systolic heart failure
  • I50.21 - Acute systolic heart failure

Combined Heart Failure

  • I50.42 - Chronic combined systolic and diastolic heart failure
  • I50.43 - Acute on chronic combined heart failure

Documentation Requirements

Your provider's note should include:

  • Specific HF type: "chronic systolic heart failure" or "HFrEF"
  • NYHA class: Functional limitation (Class I-IV)
  • Ejection fraction: Numerical value and test date
  • Etiology: Ischemic, non-ischemic, hypertensive, etc.
Tip: Avoid using I50.9 (unspecified heart failure) when more specific information is available. UnitedHealthcare reviewers prefer detailed diagnostic coding.

Clean Prior Authorization Submission

Medical Necessity Letter Checklist

Your cardiologist should include:

Clinical Problem

  • Chronic heart failure with reduced ejection fraction
  • NYHA functional class and symptoms
  • Recent hospitalizations or worsening symptoms

Prior Treatments

  • ACE inhibitor or ARB trial with specific agent, dose, duration
  • Outcome: intolerance, contraindication, or inadequate response
  • Current beta-blocker therapy and other HF medications

Rationale for Entresto

  • ACC/AHA/HFSA guidelines recommend ARNI for HFrEF
  • Expected clinical benefits: reduced hospitalization, improved symptoms
  • Plan for dose titration and monitoring

Safety Considerations

  • 36-hour ACE inhibitor washout completed
  • No history of angioedema
  • Adequate blood pressure and kidney function

Common Documentation Errors to Avoid

  • Missing ejection fraction value or date
  • Vague ACE inhibitor history ("tried in the past")
  • No cardiology involvement documented
  • Using only "CHF" without specifying systolic dysfunction
  • Concurrent ACE inhibitor or ARB listed in medication reconciliation

Common Denial Reasons & Solutions

Denial Reason How to Overturn Required Documentation
"Not medically necessary" Submit detailed letter citing HF guidelines LVEF ≤40%, NYHA class, failed ACEi/ARB
"Step therapy required" Document ACEi/ARB trial or contraindication Specific agents tried, doses, outcomes
"Non-formulary" Request formulary exception Comparative effectiveness data
"Quantity limits exceeded" Justify dosing per FDA label Weight-based calculations, titration plan
"Missing prior authorization" Resubmit with complete clinical documentation All required elements from PA form

Peer-to-Peer Review Strategy

If initially denied, request a peer-to-peer review with UnitedHealthcare's medical director:

Preparation Points:

  • Patient's clinical course and HF progression
  • Specific ACE inhibitor/ARB intolerance or failure
  • Risk of hospitalization without optimal therapy
  • Guideline citations supporting ARNI use in HFrEF

Contact Method: Call UHC provider services to schedule within 24-48 hours of denial

California Appeals Process

California provides robust appeal rights through both UnitedHealthcare's internal process and the state's Independent Medical Review system.

Internal Appeal (Required First Step)

Timeline: File within 180 days of denial Decision: 30 days for standard, 72 hours for expedited How to File: UHC member portal, written letter, or phone

Required Documentation:

  • Original denial letter
  • Updated medical necessity letter
  • Supporting clinical records
  • Guideline citations

California Independent Medical Review (IMR)

After internal appeal failure, California residents can request binding external review through the Department of Managed Health Care.

Eligibility:

  • UHC denied as "not medically necessary"
  • Completed internal appeal or 30-day delay
  • Request within 6 months of final internal denial

Process:

  • No cost to patient
  • Independent physician reviewer
  • Decision binding on UnitedHealthcare
  • Standard: 45 days, Expedited: 7 days

Success Rates: California IMR has high overturn rates for guideline-supported treatments with proper documentation.

How to Apply:

  • Online at healthhelp.ca.gov
  • Phone: 888-466-2219
  • Include all medical records and denial letters

Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals. Our platform analyzes denial letters and plan policies to draft point-by-point rebuttals aligned with payer requirements, pulling the right clinical evidence and procedural details to maximize approval chances.

Cost-Saving Options

Manufacturer Support

  • Novartis Patient Assistance: Income-based free medication
  • Copay Card: Up to $200/month savings for eligible patients
  • Application: Novartis.com patient support (verify current programs)

State Programs

  • California Prescription Drug Discount Program: Additional savings for uninsured
  • Medi-Cal: Expanded Medicaid coverage for income-eligible residents

Appeals-Specific Assistance

  • Health Consumer Alliance: Free help with insurance appeals
  • Legal Aid: For complex denials involving ERISA plans

When to Escalate to State Regulators

Contact California regulators if UnitedHealthcare:

  • Misses appeal deadlines
  • Fails to implement favorable IMR decisions
  • Repeatedly denies guideline-supported care

Department of Managed Health Care (DMHC)

  • Most UHC HMO and PPO plans
  • Help Center: 888-466-2219
  • File complaints online at dmhc.ca.gov

California Department of Insurance (CDI)

  • Some UHC PPO plans
  • Consumer Hotline: 800-927-4357
  • Verify which regulator applies to your specific plan

Frequently Asked Questions

How long does UnitedHealthcare prior authorization take in California? Standard PA decisions are typically made within 72 hours of complete submission. Expedited reviews for urgent cases may be completed in 24-48 hours.

What if Entresto is non-formulary on my UHC plan? Request a formulary exception with clinical documentation showing medical necessity. If denied, appeal through internal process then California IMR.

Can I request expedited appeal for heart failure medications? Yes, if delay could seriously jeopardize your health. Document urgent clinical need and request expedited review at both internal and IMR levels.

Does step therapy apply if I've tried ACE inhibitors outside California? Yes, UnitedHealthcare accepts prior therapy documentation from any state. Include specific agents, doses, duration, and outcomes in your PA submission.

What happens if UHC denies my IMR-approved Entresto? UnitedHealthcare must comply with IMR decisions within 5 business days. Contact DMHC immediately if they fail to implement the decision.

How does Counterforce Health help with UnitedHealthcare appeals? We analyze your specific denial and UHC policy to create targeted appeal letters with the right clinical evidence and procedural requirements, improving your chances of approval.

Can I appeal if I'm on a Medicare Advantage UHC plan? Yes, but follow Medicare appeal timelines and procedures, which may differ from commercial plans. You may have access to Medicare's external review process rather than California IMR.

What if my cardiologist won't help with the prior authorization? Contact your primary care physician or seek a second cardiology opinion. PA success often requires specialist involvement, which UHC specifically requires for Entresto.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider regarding treatment decisions and contact qualified legal counsel for complex insurance disputes. Coverage policies and appeal procedures may vary by plan type and can change over time.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.